倫敦–(BUSINESS WIRE)–(美國商業資訊)–在總部位於海德拉巴的Tej Kohli角膜研究所4週年慶之際，Tej Kohli基金會已更新其承諾，將自2020年起資助1400萬美元。在2019年期間，5,736位失明或重度視力受損者在Tej Kohli角膜研究所獲得治癒，該所是總部位於倫敦的Tej Kohli基金會與總部位於海德拉巴的世界衛生組織合作中心LV Prasad眼科研究所之間的合作。 Tej Kohli角膜研究所成立於2015年12月，為任何有需求的人士提供免費治療，以解決…
Author: Business Wire
5,736位世界最贫困人士2019年在Tej Kohli角膜研究所获赠视力恢复手术
伦敦–(BUSINESS WIRE)–(美国商业资讯)–在总部位于海得拉巴的Tej Kohli角膜研究所4周年庆之际，Tej Kohli基金会已更新其承诺，将自2020年起资助1400万美元。在2019年期间，5,736位失明或重度视力受损个体在Tej Kohli角膜研究所获得治愈，该所是总部位于伦敦的Tej Kohli基金会与总部位于海得拉巴的世界卫生组织协作中心LV Prasad眼科研究所之间的合作。 Tej Kohli角膜研究所成立于2015年12月，旨在通过向任何有需求的人士提供免费治…
5736 personas entre las más pobres del mundo recibieron el regalo de la vista en 2019 en el Tej Kohli Cornea Institute
LONDRES–(BUSINESS WIRE)–En el cuarto aniversario del Tej Kohli Cornea Institute en Hyderabad, la Fundación Tej Kohli ha renovado su compromiso de $ 14 millones de fondos a partir de 2020. Durante 2019, 5736 personas fueron curadas de ceguera o discap…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
5.736 der ärmsten Menschen der Welt erhielten 2019 im Tej Kohli Cornea Institute das Geschenk des Sehens.
LONDON–(BUSINESS WIRE)–Zum vierten Jahrestag des Bestehens des Tej Kohli Cornea Institute in Hyderabad hat die Tej Kohli Foundation ihre Zusage über die Bereitstellung von Finanzmitteln in Höhe von 14 Mio. US-$ ab 2020 erneuert. 2019 wurden am Tej Ko…
Riassunto: 5.736 tra i più poveri al mondo hanno ricevuto il dono della vista nel 2019 al Tej Kohli Cornea Institute
LONDRA–(BUSINESS WIRE)–In occasione del quarto anniversario della fondazione del Tej Kohli Cornea Institute di Hyderabad, la Tej Kohli Foundation rinnova il proprio impegno con l’elargizione di 14 milioni di dollari a partire dal 2020. Nel corso del …
5 736 des personnes les plus démunies dans le monde ont reçu le don de la vue en 2019 à l'Institut cornéen Tej Kohli
LONDRES–(BUSINESS WIRE)–À l’occasion du quatrième anniversaire de l’Institut cornéen Tej Kohli à Hyderabad, la Fondation Tej Kohli a renouvelé son engagement de 14 millions de dollars de financement à partir de 2020. Au cours de 2019, 5 736 cas de cé…
Midwest Vision Partners Announces Partnership With Cleveland Eye Clinic
CHICAGO & CLEVELAND–(BUSINESS WIRE)–Alpine Investors’ Midwest Vision Partners (“MVP”) partners with Cleveland Eye Clinic (“CEC”).
5.736 das Pessoas mais Pobres do Mundo Receberam o Dom da Visão em 2019 através do Tej Kohli Cornea Institute
LONDRES–(BUSINESS WIRE)–No quarto aniversário do Tej Kohli Cornea Institute em Hyderabad, a Fundação Tej Kohli renovou seu compromisso de US$ 14 milhões em financiamento a partir de 2020. Durante 2019, 5.736 indivíduos foram curados por cegueira ou d…
Samenvatting: 5.736 van de armste mensen ter wereld geholpen aan visuele beperking in 2019 op het Tej Kohli Cornea Institute
LONDEN–(BUSINESS WIRE)–Op de vierde verjaardag van het Tej Kohli Cornea Institute in Hyderabad heeft de Tej Kohli Foundation zijn verplichting van 14 miljoen dollar aan financiering vanaf 2020 hernieuwd. In 2019 waren 5.736 mensen genezen van blindhe…
ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institute
LONDON–(BUSINESS WIRE)–On the fourth anniversary of the Tej Kohli Cornea Institute in Hyderabad, the Tej Kohli Foundation has renewed its commitment of $14m of funding from 2020. During 2019 5,736 individuals were cured of blindness or severe visual …
Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today an…
IVERIC bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced details for its R&D Investor Symposium being held in San Francisco on Tuesday, January 14, 2020, from 6:30 to 8:00 a.m. PT.
STAAR CFO to Retire in 2020
LAKE FOREST, CA–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that following a successful 24-year career with th…
STAAR Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced it has entered into a strategic alliance with …
FDA Advisory Committee Votes Unanimously to Support the Use of Teprotumumab for the Treatment of Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon today announced the outcome of the FDA Advisory Committee meeting for teprotumumab for the treatment of thyroid eye disease (TED).
Horizon Therapeutics plc Trading Halted Today; FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting to Discuss Teprotumumab for Thyroid Eye Disease
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced that NASDAQ has halted trading of the Company’s common stock. As per the U.S. Food and Drug Administration (FDA) guidelines for new molecular entities (NMEs), the FDA Derm…
St. Johns County Public Library Offers EnChroma Glasses for Color Blindness as Part of Color Accessibility Program
ST. AUGUSTINE, Fla. & BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–The St. Johns County Public Library System will enable color blind patrons to borrow EnChroma glasses for color blindness at all six of its branches
STAAR Surgical Announces FDA IDE Clinical Study Approval
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that the FDA in a letter dated December 6,…